Glenmark Pharmaceuticals Inc., USA is recalling 5,016 blister packs of Aprepitant (generic Emend) capsules, 40 mg. This recall was initiated after customers reported that some blister packs were missing the medication capsule entirely. Without the medication, patients may miss a scheduled dose, which can lead to ineffective treatment and health complications. This drug is used to prevent nausea and vomiting caused by chemotherapy or surgery.
A missing capsule in the blister pack results in a missed dose of medication, which can fail to prevent nausea and vomiting as intended by the healthcare provider.
Refund and guidance for prescription medication.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.